Neurogenic Lower Urinary Tract Dysfunction
Conditions
Brief summary
Spinal cord injury and other systemic neurological diseases (Multiple Sclerosis, Parkinson's disease) affect the integrity of lower urinary tract (LUT) function, leading to neurogenic lower urinary tract dysfunction (NLUTD). The urodynamic investigation is the current gold-standard for evaluating LUT function. Nevertheless, the sensory situation of the LUT cannot be investigated objectively. Furthermore, the current classification of the severity of the NLUTD due to spinal cord injury (SCI) does not represent the sensory situation of the LUT. Additional investigations therefore need to be established for assessing the sensory situation of the LUT. Somatosensory evoked potentials (SEPs) are an established method for investigating the processing of sensory nervous activity. However, SEPs from the LUT of SCI individuals have not yet been investigated. A novel technique, i.e. diffusion tensor imaging (DTI), allows to process magnetic resonance images (MRI) in order to visualize nerve fibers. Using DTI, the innervation of the bladder after SCI can be visualized. The structural presentation of bladder innervation will be compared with the functional results, i.e. the SEP of the LUT in SCI individuals. The primary objective of the proposed study is to elicit and characterize (latency, amplitude) the somatosensory evoked potentials (SEPs) from the bladder in individuals suffering from neurogenic lower urinary tract dysfunction as a result of spinal cord injury. Furthermore, the SEPs from the bladder will be compared with the SEPs from peripheral nerves (N. tibialis, N. pudendus, N. medianus). Moreover, the latency and amplitude of the SEPs from the bladder of individuals with somato-sensory complete spinal cord injury will be compared with those from the bladder of individuals with somato-sensory incomplete spinal cord injury. Finally, the structural innervation of the bladder after SCI will be compared with the remaining sensory function.
Interventions
None listed
Sponsors
Swiss Paraplegic Research, Nottwil
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No
Inclusion criteria
* Informed Consent as documented by signature * Chronic SCI of a minimum of 1 year * Aetiology of SCI: traumatic
Exclusion criteria
* Age \< 18 years or \> 70 years * Aetiology of SCI: non-traumatic * History of bleeding disorder * History of chronic neuropathic pain * Intravesical botulinum toxin injections \< 12 months ago * Bladder management using indwelling catheters (suprapubic, transurethral) * Bladder augmentation * Sacral deafferentation * Sacral neuromodulation * Acute, symptomatic urinary tract infection * Pregnancy * Urolithiasis * Bladder cancer *
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| occurrence of somatosensory evoked potentials from the bladder | within 1 week after enrollment into study |
Secondary
| Measure | Time frame |
|---|---|
| peak-to-peak amplitude of somatosensory evoked potentials | within 1 week after enrollment into study |
| nerve fiber density around bladder | within 1 week after enrollment into study |
| fractional anisotropy of nerve fibers around bladder | within 1 week after enrollment into study |
| apparent diffusion coefficient of nerve fibers around bladder | within 1 week after enrollment into study |
| latency of somatosensory evoked potentials | within 1 week after enrollment into study |
Other
| Measure | Time frame | Description |
|---|---|---|
| severity of spinal cord injury | 1st day | American Association of Spinal Cord Injury Impairment Score |
| gender | 1st day | — |
| age | 1st day | — |
Countries
Switzerland
Outcome results
None listed